Literature DB >> 20701597

Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007.

K Knudsen1, U Jonsson, J Abrahamsson.   

Abstract

BACKGROUND: gamma-Hydroxybutyrate (GHB) is a drug of abuse with a status as being safe. In spite of a reputation of low toxicity, a huge number of deaths associated with this drug have been recorded during recent years in Sweden. It is unclear whether coingestion with other drugs or ethanol causes death in GHB overdoses or whether GHB itself is the main cause of death.
OBJECTIVES: The aim of this study was to analyze the cause of death in GHB-related fatalities seen in our region.
METHODS: All cases of deaths with GHB during the year 2000-2007 in the region of western Sweden were studied retrospectively. The cases were classified as either GHB poisonings without any, with a minor or a major influence of other drugs on the cause of death.
RESULTS: Twenty-three cases were diagnosed as deaths due to GHB overdose. Ninety-one percent coingested other substances. Ninety-one percent of the decedents were male. Age varied between 16 and 46, with the median age at 25 years. Forty-three percent of the cases were classified as GHB poisonings without any or a minor influence of other drugs on the cause of death. Thirty percent also ingested ethanol. Two patients (9%) were only intoxicated with GHB.
CONCLUSIONS: Intoxication with GHB carries some mortality. Combining GHB with ethanol does not explain the many deaths in our region, nor do extremely high plasma concentrations of GHB. The intake of opioids increases the toxicity of GHB. The drug itself has such biological activities that an overdose is dangerous and may lead to death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20701597     DOI: 10.1111/j.1399-6576.2010.02278.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  9 in total

1.  Brain uptake of the drug of abuse γ-hydroxybutyric acid in rats.

Authors:  Samuel A Roiko; Melanie A Felmlee; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2011-10-21       Impact factor: 3.922

2.  Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.

Authors:  Bridget L Morse; Gurkishan S Chadha; Melanie A Felmlee; Kristin E Follman; Marilyn E Morris
Journal:  Am J Drug Alcohol Abuse       Date:  2017-06-29       Impact factor: 3.829

3.  The challenge of post-mortem GHB analysis: storage conditions and specimen types are both important.

Authors:  J Kietzerow; B Otto; N Wilke; H Rohde; S Iwersen-Bergmann; H Andresen-Streichert
Journal:  Int J Legal Med       Date:  2019-10-09       Impact factor: 2.686

4.  Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs.

Authors:  Hilke Andresen-Streichert; P Jensen; J Kietzerow; M Schrot; N Wilke; E Vettorazzi; A Mueller; S Iwersen-Bergmann
Journal:  Int J Legal Med       Date:  2014-08-02       Impact factor: 2.686

Review 5.  GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.

Authors:  Francesco P Busardò; Alan W Jones
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

6.  Symptoms and signs in interpreting gamma-hydroxybutyrate (GHB) intoxication - an explorative study.

Authors:  Margareta Warrén Stomberg; Kai Knudsen; Henrik Stomberg; Ingela Skärsäter
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-04-23       Impact factor: 2.953

7.  Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.

Authors:  Evangelia Liakoni; Fabio Walther; Christian H Nickel; Matthias E Liechti
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-08-31       Impact factor: 2.953

8.  Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses.

Authors:  Desiree Madah-Amiri; Lars Myrmel; Guttorm Brattebø
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-09-22       Impact factor: 2.953

Review 9.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.